Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 50-56

  Zhang, Shengle ^a   Zhang, Helen S ^a   Cordon Cardo, Carlos ^a   Reuter, Victor E ^a   Singhal, Anil K ^b   Lloyd, Kenneth O ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BioNexus Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BREAST CANCER; CANCER IMMUNOLOGY; HUMAN; HUMAN TISSUE; LEYDIG CELL; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; UTERUS CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; MICE; NEOPLASMS;

EID: 0030765682     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.0.CO;2-0     Document Type: Article

References (26)

1. BLASZCZYK, M., PAK, K.Y., HERLYN, M., SEARS, H.F., and STEPLEWSKI, Z., Characterization of lewis antigens in normal colon and gastrointestinal adenocarcinomas. Proc. nat. Acad. Sci. (Wash.), 82, 3552-3556 (1985).
2. CAPURRO, M., BOVER, L., PORTELA, P., LIVINGSTON, P.O., and MORDOH, J., FC-2.15, a monocl;onal antibody active against human breast cancer, specifically recognizes Lewis X hapten. Cancer Immunol. Immunother (1997) in press.
3. COLCHER, D., HORAN HAND, P., NUTI, M., and SCHLOM, J., A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. nat. Acad. Sci. (Wash.), 78, 3199-3203 (1981).
4. y determinants in urothelial carcinoma. Cancer Res., 48, 4113-4120 (1988).
5. x as a new tumor-associated antigen. Cancer Res., 44, 5279-5285 (1984).
6. GILEWSKI, T., ADLURI, R., HOUGHTON, A., NORTON, L., and LIVINGSTON, P., Preliminary results: vaccination of breast cancer patients lacking identifiable disease with MUC1-keyhole limpet hemocyanin (KLH) conjugate and QS21. Amer. Soc. clin. Oncol. Proc., 15, 555 (1996).
7. x and sulfated glycans modulate this binding. Biochem. biophys. Res. Comm., 181, 1223-1230 (1991).
8. HELLSTRÖM, I., GARRIGUES, H.J., GARRIGUES, U. and HELLSTRÖM, K.E., Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res., 50, 2183-2187 (1990).
9. HERLYN, M., SEARS, H.F., STEPLEWSKI, Z., and KOPROWSKI, H., Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric and pancreatic carcinoma. J. clin. Immunol., 2, 135-140 (1982).
10. Hsu, S.M., RAIN, L., and FANGER, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques; a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
11. IRIE, R.F., MATSUKI, T., and MORTON, D.L., Human monoclonal antibody to ganglioside GM2 for melanoma treatment. Lancet, I, 786 (1989).
12. ITZKOWITZ, S.H., YUAN, M., MONTGOMERY, C.K., KJELDSEN, T., TAKAHASHI, H.K., BIGBEE, W.L., and KIM, YOUNG, Y.S., Expression of Tn, sialosyl-Tn. and T antigens in human colon cancer. Cancer Res., 49, 197-204 (1989).
13. a expression and tumor progression in melanoma. Cancer Res., 55, 1748-1751 (1995).
14. y determinants. Proc. nat. Acad. Sci. (Wash.), 91, 12957-12961 (1994).
15. LIVINGSTON, P.O., WONG, G.Y.C., ADLURI, S., TAO, Y., PADAVAN, M., PARENTE, R., HANLON, C., CALVES, M.J., HELLING, F., RITTER, G., OETTGEN, H.F., and OLD, L.J., Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. clin. Oncol., 12, 1036-1044 (1994).
16. LLOYD, K.O., Blood group antigens as markers for normal differentiation and malignant change in human tissues. Amer. J. clin, Pathol., 87, 129 (1987).
17. LONGENECKER, B.M., RAHMAN, A.F.R., LEIGH, J.B., PURSER, R.A., GREENBERG, A.H., WILLANS, D.J., KELLER, O., PETRIK, P.K., THAY, T.Y., SURESH, M.R., and NOUJAIM, A.A., Monoclonal antibody against a cryptic carbohydrate antigen of marine and human lymphocytes. I. Antigen expression in non-cryptic or unsubstituted form on certain murine lymphomas. on a spontaneous murine mammary carcinoma, and on several human adenocarcinomas. Int. J. Cancer, 33, 123-129 (1984).
18. MACLEAN, G.D., REDDISH, M., KOGANTY, R.R., WONG, T., GANDHI, S., SMOLENSKI, M., SAMUEL, J., NABHOLTZ, J.M., and LONGENECKER, B.M., Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol. Immunother., 36, 215-222 (1993).
19. MACLEAN, G.D., YACYSHYN-BOWEN, M.B., SAMUEL, J., MEIKLE, A., STUART, G., NATION, J., POPPEMA, S., JERRY, M., KOGANTY, R.R., WONG, T., and LONGENECKER, B.M., Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J. Immunother., 11, 292-296 (1992).
20. MORDOH, J., SILVA, C., ALBARELLOS, M., BRAVO, A.I., and KAIRIYAMA, C., Phase I clinical trial in cancer patients of a new monoclonal antibody FC-2.12 reacting with tumor proliferating cells. I Immunother., 17, 151-180 (1995).
21. MURARO, R., KUROKI, M., WUNDERLICH, D., POOLE, D.J., COLCHER, D., THOR, A., GREINER, J.W., SIMPSON, J.F., MOLINOLO, A., NOGUCHI, P., and SCHLOM, J., Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res., 48, 4588-4596 (1988).
22. b. X. and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res., 46, 1553-1561 (1986).
23. xcontaining glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res., 50, 1375-1380 (1990).
24. SPRINGER, G.F., T and Tn. General carcinoma autoantigens. Science, 224, 1198-1206 (1984).
25. y) blood group antigen expression in epithelial ovarian cancer, Int. J. Cancer, 65, 406-412 (1996).
26. ZHANG, S., CORDON-CARDO, C., ZHANG, H.S., REUTER, V.E., ADLURI, S., HAMILTON, W.B., LLOYD, K.O., and LIVINGSTON, P.O., Selection of carbohydrate tumor antigens as targets for immune attack using immunohistochemistry. I. Focus on gangliosides. Int. J. Cancer, 73, 42-19 (1997).